Narrative MedicineNCT06436963
Exploring the Application of Narrative Medicine Combined With Case-Based Learning in the Standardized Training of General Practice Residents
A study testing narrative medicine training combined with CBL training and CBL training in people with Narrative Medicine and Case-based Learning, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.
Trial summary
This was a prospective, longitudinal, single-center nonrandomized controlled study. A total of 36 first- and second-year general practice residents of Zhejiang University School of Medicine were voluntarily enrolled in the experimental group. The remaining 9 residents served as a control group. Read more about this study
- Who is it for?
- Ages 24 to 28 years
- Conditions the study is for
- Narrative Medicine, Case-based Learning
- What is being tested?
- narrative medicine training combined with CBL training and CBL training
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 45 participants
- Where
- 1 siteChina
- Study dates
- 1 Jul 2022to 31 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 24 to 28 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- first- and second-year general practice residents of Zhejiang University School of Medicine
Who cannot join
- third-year general practice residents of Zhejiang University School of Medicine
Trial locations and contacts
1 site in 1 country.
China1 site
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310009
About this study
Official title: Narrative Medicine Combined With Case-Based Learning
This was a prospective, longitudinal, single-center nonrandomized controlled study. A total of 36 first- and second-year general practice residents of Zhejiang University School of Medicine were voluntarily enrolled in the experimental group. The remaining 9 residents served as a control group. The experimental group received narrative medicine training combined with CBL training. The control group received normal CBL training. None of the participants had previously had any training in narrative medicine. Teaching evaluation scores were measured for all subjects at baseline and 1 year after the training.
- Conditions
- Narrative Medicine, Case-based Learning
- Being tested
- narrative medicine training combined with CBL training, CBL training
- Medical subject headings
- Narrative Medicine
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
narrative medicine training combined with CBL trainingBehavioural
The experimental group received narrative medicine training combined with CBL training.
CBL trainingBehavioural
The control group received normal CBL training.
| Study group | Role | What they receive |
|---|---|---|
| narrative medicine training combined with CBL training | Experimental | The experimental group received narrative medicine training combined with CBL training Receives: Behavioral: narrative medicine training combined with CBL training |
| CBL training | Active comparator | The control group received normal CBL training Receives: Behavioral: CBL training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Satisfaction Survey of Residents in the Experimental Group
The satisfaction survey was divided into five levels, ranging from "strongly agree" to "strongly disagree". The higher percent of agree means better result.
Measured: 12 months
Comparison of the SEGUE scale scores Between the Experimental Group and the Control Group
The SEGUE scale scores were generated by assigning a value of "1" for "yes", "0" for "no" and "0.5" for "cannot answer". High scores indicate stronger clinical communication skills.
Measured: 12 months
Comparison of the JSE-S scale scores Between the Experimental Group and the Control Group
The JSE-S scale scores adopts a 7-point Likert scale ranging from "strongly disagree" to "strongly agree". The higher total score indicating a greater level of empathy.
Measured: 12 months
Comparison of the SEGUE scale in Different Grades Before and After Training in the Experimental Group
The SEGUE scale scores were generated by assigning a value of "1" for "yes", "0" for "no" and "0.5" for "cannot answer". High scores indicate stronger clinical communication skills.
Measured: 12 months
Comparison of the JSE-S scale in Different Grades Before and After Training in the Experimental Group
The JSE-S scale scores adopts a 7-point Likert scale ranging from "strongly disagree" to "strongly agree". The higher total score indicating a greater level of empathy.
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 May 2024
- Study start1 Jul 2022
- Primary completion31 Dec 2023
- Study completion31 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Narrative MedicineStudies of the same condition, open and under way.
- More trials run by Second Affiliated Hospital, Zhejiang University, School of MedicineThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 45 participants (actual)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06436963
- Sponsor's protocol ID
- 2022KY815
- Status last verified
- May 2024
- First submitted
- 17 May 2024
- Last updated
- 31 May 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Narrative Medicine Combined With Case-Based Learning
- ClinicalTrials.gov ID
- NCT06436963
- Acronym / sponsor ID
- 2022KY815
- Conditions
- Narrative Medicine, Case-based Learning
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 45 participants (actual)
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of MedicineUniversity, hospital or other
- Study start
- 1 Jul 2022 (actual)
- Primary completion
- 31 Dec 2023 (actual)
- Study completion
- 31 Dec 2023 (actual)
- First posted
- 31 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This was a prospective, longitudinal, single-center nonrandomized controlled study. A total of 36 first- and second-year general practice residents of Zhejiang University School of Medicine were voluntarily enrolled in the experimental group. The remaining 9 residents served as a control group. The experimental group received narrative medicine training combined with CBL training. The control group received normal CBL training. None of the participants had previously had any training in narrative medicine. Teaching evaluation scores were measured for all subjects at baseline and 1 year after the training.
Study design
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| narrative medicine training combined with CBL training | Experimental | Behavioral: narrative medicine training combined with CBL trainingThe experimental group received narrative medicine training combined with CBL training |
| CBL training | Active comparator | Behavioral: CBL trainingThe control group received normal CBL training |
Who may qualify
- Ages
- 24 to 28 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- first- and second-year general practice residents of Zhejiang University School of Medicine
Key exclusion criteria (1 listed)
- third-year general practice residents of Zhejiang University School of Medicine
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| narrative medicine training combined with CBL trainingThe experimental group received narrative medicine training combined with CBL training. | Behavioural | narrative medicine training combined with CBL training |
| CBL trainingThe control group received normal CBL training. | Behavioural | CBL training |
Primary outcome
Satisfaction Survey of Residents in the Experimental Group
Time frame: 12 months
The satisfaction survey was divided into five levels, ranging from "strongly agree" to "strongly disagree". The higher percent of agree means better result.
Comparison of the SEGUE scale scores Between the Experimental Group and the Control Group
Time frame: 12 months
The SEGUE scale scores were generated by assigning a value of "1" for "yes", "0" for "no" and "0.5" for "cannot answer". High scores indicate stronger clinical communication skills.
Comparison of the JSE-S scale scores Between the Experimental Group and the Control Group
Time frame: 12 months
The JSE-S scale scores adopts a 7-point Likert scale ranging from "strongly disagree" to "strongly agree". The higher total score indicating a greater level of empathy.
Comparison of the SEGUE scale in Different Grades Before and After Training in the Experimental Group
Time frame: 12 months
The SEGUE scale scores were generated by assigning a value of "1" for "yes", "0" for "no" and "0.5" for "cannot answer". High scores indicate stronger clinical communication skills.
Comparison of the JSE-S scale in Different Grades Before and After Training in the Experimental Group
Time frame: 12 months
The JSE-S scale scores adopts a 7-point Likert scale ranging from "strongly disagree" to "strongly agree". The higher total score indicating a greater level of empathy.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 May 2024.
- Individual participant dataSharing planned: No
Related trials for Narrative Medicine
Not yet recruiting
Peer-led, Mobile App Supported Linkage to Opioid Use Disorder Treatment
Opioid Use Disorder
Not yet recruiting
Narrative Medicine Effects on Burnout and Stress
Healthcare Professionals
RecruitingObservational study
MyPaTH Story Booth
Narrative Medicine
Recruiting
Breaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions
DSD, Hypospadias
Enrolling by invitation
Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation
Atrial Fibrillation, Atrial Flutter
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing narrative medicine training combined with CBL training and CBL training in people with Narrative Medicine and Case-based Learning, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Satisfaction Survey of Residents in the Experimental Group (time frame: 12 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 May 2024.